BioSig’s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium
19 août 2021 11h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annual Heart Rhythm 2021 convention
20 juil. 2021 14h00 HE
|
BioSig Technologies, Inc.
Westport, CT, July 20, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology
13 juil. 2021 14h30 HE
|
BioSig Technologies, Inc.
Westport, CT, July 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmia Care
12 juil. 2021 10h30 HE
|
BioSig Technologies, Inc.
Westport, CT, July 12, 2021 (GLOBE NEWSWIRE) -- Company to present results from PURE EP 2.0 Study - a multi-center, blinded, and randomized clinical trialLeading physicians evaluated signal data...
BioSig Announces Closing of Public Offering of Common Stock
07 juil. 2021 16h10 HE
|
BioSig Technologies, Inc.
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology
07 juil. 2021 09h36 HE
|
BioSig Technologies, Inc.
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Announces Pricing of Public Offering of Common Stock
02 juil. 2021 08h15 HE
|
BioSig Technologies, Inc.
Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Announces Proposed Public Offering of Common Stock
01 juil. 2021 16h05 HE
|
BioSig Technologies, Inc.
Westport, CT, July 01, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
30 juin 2021 09h35 HE
|
BioSig Technologies, Inc.
Westport, CT, June 30, 2021 (GLOBE NEWSWIRE) -- The Company recently increased its procedural volume targets due to accelerated technology usageBioSig expands its commercial team to target...
BioSig’s Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhythmia Technologies Retreat
28 juin 2021 09h45 HE
|
BioSig Technologies, Inc.
Westport, CT, June 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...